X-Linked Lymphoproliferative Syndrome Recruiting Phase 2 Trials for Melphalan (DB01042)

Also known as: X-linked Lymphoproliferative Syndrome / X-linked lymphoproliferative disease / Duncan's syndrome / X-Linked Lymphoproliferative Disorder

IndicationStatusPhase
DBCOND0029164 (X-Linked Lymphoproliferative Syndrome)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01821781Immune Disorder HSCT ProtocolTreatment